Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.32 |
| ▸ | CA6 | P23280 | 3/20 | 0.32 |
| ▸ | CA7 | P43166 | 3/20 | 0.32 |
| ▸ | CA9 | Q16790 | 3/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 3/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA3 | P07451 | 2/20 | 0.31 |
| ▸ | CA4 | P22748 | 2/20 | 0.31 |
| ▸ | CA5A | P35218 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8466256 | 0.96 | CA12 (0.38) | CA12CA6CA7CA9CA14 | |
| SCHEMBL28808057 | 0.93 | CASP2 (0.35) | CA12CA6CA7CA9CA14 | |
| SCHEMBL28306368 | 0.90 | CA12 (0.36) | CA12CA6CA7CA9CA14 | |
| SCHEMBL143042 | 0.87 | TSHR (0.38) | LMNAALDH1A1 | |
| SCHEMBL692270 | 0.85 | CA12 (0.35) | CA12CA6CA7CA9CA14 | |
| SCHEMBL30801 | 0.84 | CA12 (0.43) | CA12CA6CA7CA9CA14 | |
| SCHEMBL29140672 | 0.84 | ALDH1A1 (0.41) | LMNAALDH1A1 | |
| SCHEMBL29034749 | 0.82 | CA12 (0.42) | CA12CA6CA7CA9CA14 | |
| SCHEMBL20602110 | 0.82 | CA12 (0.37) | CA12CA6CA7CA9CA14 | |
| SCHEMBL28663704 | 0.82 | RELA (0.37) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10875879-B2 | Compositions, synthesis, and uses of hydrolyzable silane modified cashew nut shell liquid derivatives | CARDOLITE CORPORATION (US) | 2020-12-29 | — | — | US | claimed |
| US-20190077815-A1 | COMPOSITIONS, SYNTHESIS, AND USES OF HYDROLYZABLE SILANE MODIFIED CASHEW NUT SHELL LIQUID DERIVATIVES | CARDOLITE CORPORATION | 2019-03-14 | — | — | US | claimed |
| EP-3065884-A1 | ANTICORROSION LAYER AND PROCESS FOR PRODUCTION THEREOF | Technische Universität Bergakademie Freiberg (DE) | 2016-09-14 | — | — | EP | claimed |
| CN-102143791-B | Aldehyde reducing compositions | ARMSTRONG WORLD INDUSTRIES, INC. (US) | 2015-11-25 | — | — | CN | claimed |
| WO-2015067776-A1 | ANTICORROSION LAYER AND PROCESS FOR PRODUCTION THEREOF | TECHNISCHE UNIVERSITÄT BERGAKADEMIE FREIBERG (DE) | 2015-05-14 | — | — | WO | claimed |
| US-20040236399-A1 | Stent with improved surface adhesion | MEDTRONIC VASCULAR, INC. | 2004-11-25 | — | — | US | claimed |
| CN-119365548-A | Two-component room temperature rapid-curing resin composition and article | 信越化学工业株式会社 | 2025-01-24 | — | — | CN | disclosed |
| EP-4466300-A1 | A THERMOSET COMPOSITE COMPRISING A CROSSLINKED IMIDE EXTENDED COMPOUND | Rogers Corporation (US) | 2024-11-27 | — | — | EP | disclosed |
| CN-118742428-A | Multilayer composite material | SABIC环球技术有限责任公司 | 2024-10-01 | — | — | CN | disclosed |
| CN-118613361-A | Foaming assembly | SABIC环球技术有限责任公司 | 2024-09-06 | — | — | CN | disclosed |
| EP-3875541-B1 | COMPOSITION AND METHOD FOR PRODUCING SILICONE MASSES AND USE THEREOF | POLYU GMBH (DE) | 2024-08-14 | — | — | EP | disclosed |
| WO-2024138507-A1 | BLACK LIQUID CRYSTALLINE POLYMER COMPOSITION WITH LOW DISSIPATION FACTOR | TICONA LLC (US) | 2024-07-04 | — | — | WO | disclosed |
| US-20240203624-A1 | Y-TYPE HEXAFERRITE, METHOD OF MANUFACTURE, AND USES THEREOF | ROGERS CORP (US) | 2024-06-20 | — | — | US | disclosed |
| US-5331059-A | Absorbent materials, acrylic acid polymers crosslinked with diglycidyl phosphonates | CASSELLA AKTIENGESELLSCHAFT (DE) | 1994-07-19 | — | — | US | disclosed |
| WO-1993012184-A1 | PROCESS FOR PARTICLE ADSORPTION | ROHM AND HAAS COMPANY (US) | 1993-06-24 | — | — | WO | disclosed |
| EP-0143541-B1 | METHOD FOR PRODUCING SILICONE AQUEOUS EMULSION COMPOSITIONS | Toray Silicone Company Limited (JP) | 1989-05-31 | — | — | EP | disclosed |
| EP-0234308-A2 | Coating composition containing an ungelled reaction product as a curative | PPG INDUSTRIES, INC. (US) | 1987-09-02 | — | — | EP | disclosed |
| EP-0205827-A2 | Acrylic polymers containing hydrolyzable moieties from organosilane compounds | PPG INDUSTRIES, INC. (US) | 1986-12-30 | — | — | EP | disclosed |
| EP-0076490-A1 | Paper coating agent | KURARAY CO., LTD. (JP) | 1983-04-13 | — | — | EP | disclosed |
| EP-0035130-A1 | Process for obtaining a transparent coating on panes of normal or safety glass | SOCIETA ITALIANA VETRO - SIV SpA (IT) | 1981-09-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190077815-A1 | COMPOSITIONS, SYNTHESIS, AND USES OF HYDROLYZABLE SILANE MODIFIED CASHEW NUT SHELL LIQUID DERIVATIVES | NANS, SGMS1, FUT6 | CA12 823/4885CA6 214/4885CA7 915/4885 |
| US-10875879-B2 | Compositions, synthesis, and uses of hydrolyzable silane modified cashew nut shell liquid derivatives | NANS, SGMS1, FUT6 | CA12 823/4885CA6 214/4885CA7 915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.